Search Within

Hematology-Oncology Fellows

Formats
  1. Meeting Abstract (2134)
  2. Journal Article (1760)
  3. Review (262)
  4. Editorial (133)
  5. Research Letter (85)
  6. Correspondence (45)
  7. Book Section (31)
  8. Guidelines (25)
  9. Miscellaneous (14)
  10. Conference Paper (8)
Groups
  1. Department of Medicine (4178)
  2. Weinberg Fellows (2759)
  3. Hematologic Malignancies, Division of (2494)
  4. Solid Tumor Oncology Division (2427)
  5. Center for Hematologic Malignancies (1946)
  6. GSK Faculty (1881)

More Groups

People
  1. Sergio Giralt (433)
  2. Michael Scordo (389)
  3. Gunjan Shah (348)
  4. Miguel-Angel Perales (338)
  5. Sean Devlin (289)
  6. Marcel Van Den Brink (263)

More People

Years
  1. 2025 (349)
  2. 2024 (636)
  3. 2023 (600)
  4. 2022 (628)
  5. 2021 (503)
  6. 2020 (496)

More Years

Publications
  1. Blood (713)
  2. Journal of Clinical Oncology (685)
  3. Annals of Oncology (133)
  4. Clinical Cancer Research (131)
  5. Cancer Research (126)
  6. Biology of Blood and Marrow Transplantation (124)

More Publications

Publishers
  1. American Society of Hematology (806)
  2. American Society of Clinical Oncology (774)
  3. Elsevier Inc. (544)
  4. Nature Publishing Group (359)
  5. American Association for Cancer Research (352)
  6. Oxford University Press (211)

More Publishers

Results (4497)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genomic biomarkers of response to lenvatinib/pembrolizumab (Len/Pembro) in patients with advanced renal cell carcinoma
    Meeting Abstract

    Lee, C. H.; DiNatale, R. G.; Chowell, D.; Krishna, C.; Makarov, V.; Shapnik, N.; Murray, S. J.; Carlo, M. I.; Voss, M. H.; Feldman, D. R.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Comparative circulating tumor DNA (ctD-NA) genomic profiling in 110 patients with advanced renal cell carcinoma
    Meeting Abstract

    Kotecha, R.; Gedvilaite, E.; Murray, S. J.; Foster, A.; Motzer, R. J.; Tsui, D.; Voss, M. H.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Causes and patterns of mortality in patients with lethal germ cell tumor (GCT)
    Meeting Abstract

    Hamid, A.; Funt, S. A.; Markt, S. C.; Bromberg, M.; O'Donnell, D.; Adra, N.; Taza, F.; Albany, C.; Krailo, M. D.; Frazier, A. L.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Response to systemic therapy in patients with metastatic fumarate hydratase (FH) deficient renal cell carcinoma (RCC)
    Meeting Abstract

    Gleeson, J. P.; Nikolovski, I.; Kotecha, R.; Ged, Y.; Shapnik, N.; Knezevic, A.; Feldman, D. R.; Lee, C. H.; Voss, M. H.; Chen, Y. B.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Adverse event profiles of apalutamide, enzalutamide, and darolutamide in SPARTAN, PROSPER, and ARAMIS: How confident are we about which drug is safest?
    Meeting Abstract

    Drago, J. Z.; Kantoff, P. W.; Stopsack, K. H.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Differential expression of melanoma-associated antigen A3/6 and associated immune molecules prior to and post treatment with immune checkpoint inhibitors (ICI) in patients with mUC
    Meeting Abstract

    Faiena, I.; Funt, S. A.; Astrow, S. H.; Dorff, T. B.; Adhikary, S.; Gorgan, T.; Rosenberg, J. E.; Elashoff, D.; Pantuck, A. J.; Drakaki, A.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Detailed evaluation of hearing loss (HL) associated with high-dose (HD) carboplatin for salvage treatment of germ cell tumors (GCT)
    Meeting Abstract

    Feldman, D. R.; Knezevic, A.; Wilson, K.; Bromberg, M.; Budnick, A.; McHugh, D. J.; Larsen, E.; Bajorin, D. F.; Motzer, R. J.; Tonorezos, E. S.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Defining the genetic evolution of epigenetic alterations in bladder cancer
    Meeting Abstract

    Clinton, T. N.; Wise, H.; Almassi, N.; Chavan, S. S.; Hu, W.; Gao, S. P.; Hanrahan, A.; Dason, S.; Pietzak, E. J.; Carlo, M. I.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Marker lesion study of oral FGFR inhibitor BGJ398 in patients with FGFR3-altered intermediate-risk nonmuscle-invasive bladder cancer
    Meeting Abstract

    Cha, E. K.; Iyer, G.; Funt, S. A.; Regazzi, A. M.; Francis, J.; Heinemann, M. H.; Ostrovnaya, I.; Dalbagni, G.; Bajorin, D. F.; Bochner, B. H.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Fraction genome altered (FGA) to regulate both cell autonomous and non-cell autonomous functions in prostate cancer and its effect on prostate cancer aggressiveness
    Meeting Abstract

    Chakraborty, G.; Ghosh, A.; Nandakumar, S.; Armenia, J.; Mazzu, Y. Z.; Atiq, M. O.; Lee, G. S. M.; Mucci, L. A.; Merghoub, T.; Wolchok, J. D.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save